Etomoxir, 98%

Name: Etomoxir, 98% | 124083-20-1
Brand: J&K Chemical
SKU: JK500549_100_MG
Price: 439.62 USD
Availability: OutOfStock

Cat. No JK500549_100_MG

Vendor: J&K Chemical

Product Information

Product Name

Etomoxir, 98%

Brand Name

J&K

Product Number

500549

CAS

124083-20-1

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

9840324

IUPAC Name

ethyl (2R)-2-6-(4-chlorophenoxy)hexyloxirane-2-carboxylate

InChI Key

DZLOHEOHWICNIL-QGZVFWFLSA-N

SMILES

CCOC(=O)C@1(CO1)CCCCCCOC2=CC=C(C=C2)Cl

References Data Source From Pubchem

BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA -mutant ovarian cancer

Publication Name: Science Translational Medicine

Publication Date: 2023-06-21

DOI: 10.1126/scitranslmed.add7872

Access to Chiral Tertiary Alkyl Halides by Catalytic Reductive Desymmetrization of Malonic Esters

Publication Name: Synfacts

Publication Date: 2022-04-20

DOI: 10.1055/s-0041-1738042

High-Throughput Screening to Identify Inhibitors of the Type I Interferon–Major Histocompatibility Complex Class I Pathway in Skeletal Muscle

Publication Name: ACS Chemical Biology

Publication Date: 2020-05-27

DOI: 10.1021/acschembio.0c00343

Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening

Publication Name: SLAS discovery : advancing life sciences R & D

Publication Date: 2020-01

DOI: 10.1177/2472555219873068

Ovarian Cancer Relies on Glucose Transporter 1 to Fuel Glycolysis and Growth: Anti-Tumor Activity of BAY-876

Publication Name: Cancers

Publication Date: 2018-12-31

DOI: 10.3390/cancers11010033

Etomoxir, 98%

Product Information

General Information

References Data Source From Pubchem

BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA -mutant ovarian cancer

Access to Chiral Tertiary Alkyl Halides by Catalytic Reductive Desymmetrization of Malonic Esters

High-Throughput Screening to Identify Inhibitors of the Type I Interferon–Major Histocompatibility Complex Class I Pathway in Skeletal Muscle

Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening

Ovarian Cancer Relies on Glucose Transporter 1 to Fuel Glycolysis and Growth: Anti-Tumor Activity of BAY-876

Etomoxir, 98%

About Us

Popular Searches

Contact

#title#

Features
Availability:
Price
Options
Actions

Etomoxir, 98%

Product Information

General Information

References Data Source From Pubchem

BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA -mutant ovarian cancer

Access to Chiral Tertiary Alkyl Halides by Catalytic Reductive Desymmetrization of Malonic Esters

High-Throughput Screening to Identify Inhibitors of the Type I Interferon–Major Histocompatibility Complex Class I Pathway in Skeletal Muscle

Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening

Ovarian Cancer Relies on Glucose Transporter 1 to Fuel Glycolysis and Growth: Anti-Tumor Activity of BAY-876

Etomoxir, 98%

Related Product

#title#

Login

Register